Jiangsu Gdk Biological Technology Co., Ltd (SHA:688670)

SHA:688670 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	37.97	83.42	70.44	174.73	36.69	88.01
Short-Term Investments	-	153.55	361.95	-	-	-
Trading Asset Securities	122.64	195.39	175.42	390.57	657.31	40
Cash & Short-Term Investments	160.61	432.37	607.82	565.3	694	128.01
Cash Growth	-45.47%	-28.87%	7.52%	-18.55%	442.13%	667.38%
Accounts Receivable	123.47	112.96	81.24	341.11	342.76	354.95
Other Receivables	0.51	0.5	0.48	0.54	0.89	0.39
Receivables	123.98	113.45	81.71	341.65	343.65	355.34
Inventory	58.38	34.93	21.98	31.95	27.98	33.25
Other Current Assets	123.42	1.83	10.74	12.11	4.08	6.18
Total Current Assets	466.39	582.58	722.24	951.02	1,070	522.79
Property, Plant & Equipment	821.16	809.46	794.95	785.9	523.89	193.08
Other Intangible Assets	26.46	30.22	35.32	40.41	45.46	49.53
Long-Term Deferred Tax Assets	78.47	55.81	33.31	17.75	21.79	6.8
Long-Term Deferred Charges	52.35	51.36	42.42	27.81	15.46	1.89
Other Long-Term Assets	3.33	3.48	3.36	3.89	78.19	3.9
Total Assets	1,448	1,533	1,632	1,827	1,754	777.98
Accounts Payable	73.42	25.06	11.48	9.66	7.52	16.41
Accrued Expenses	10.51	62.7	62.87	144.52	132.36	165.62
Short-Term Debt	58.04	47.63	64.06	42.04	10.01	296.75
Current Income Taxes Payable	2.85	-	-	-	-	5.99
Current Unearned Revenue	-	-	-	0.05	0.05	0.9
Other Current Liabilities	78.23	75.49	88.93	106.23	71.73	23.4
Total Current Liabilities	223.04	210.88	227.34	302.5	221.68	509.07
Long-Term Unearned Revenue	25.38	25.11	25.56	25.98	25.67	26.4
Long-Term Deferred Tax Liabilities	0.06	0.09	0.06	0.09	0.35	-
Other Long-Term Liabilities	8.57	19.25	7.56	38.54	45.42	-
Total Liabilities	257.05	255.33	260.52	367.11	293.12	535.47
Common Stock	123.2	123.2	123.2	88	88	66
Additional Paid-In Capital	1,116	1,116	1,116	1,151	1,151	36.24
Retained Earnings	-48.29	38.18	131.68	220.27	222.73	140.27
Shareholders' Equity	1,191	1,278	1,371	1,460	1,461	242.5
Total Liabilities & Equity	1,448	1,533	1,632	1,827	1,754	777.98
Total Debt	58.04	47.63	64.06	42.04	10.01	296.75
Net Cash (Debt)	102.57	384.74	543.76	523.26	683.99	-168.73
Net Cash Growth	-56.33%	-29.24%	3.92%	-23.50%	-	-
Net Cash Per Share	0.84	3.13	4.44	4.28	6.52	-1.83
Filing Date Shares Outstanding	123.2	123.2	123.2	123.2	123.2	92.4
Total Common Shares Outstanding	123.2	123.2	123.2	123.2	123.2	92.4
Working Capital	243.35	371.7	494.91	648.52	848.02	13.71
Book Value Per Share	9.67	10.37	11.13	11.85	11.86	2.62
Tangible Book Value	1,165	1,247	1,336	1,419	1,416	192.98
Tangible Book Value Per Share	9.45	10.12	10.84	11.52	11.49	2.09
Buildings	-	117.03	107.68	107.22	107.18	107.18
Machinery	-	221.67	206.49	204.15	196.33	169.09
Construction In Progress	-	661.51	649.46	619.86	341.8	15.13

Source: S&P Global Market Intelligence. Standard template. Financial Sources.